Trial Information

Summary: An Investigational, Injectable Medication for People with Severe Persistent Asthma

Health Sciences Research Center is conducting a research study to evaluate the effectiveness and safety of an investigational, injectable medication for patients with severe persistent symptomatic asthma.

You may participate in this study if you:

• are 18 years and older,
• have had a diagnosis of asthma for greater than 3 years,
• have been diagnosed with severe, persistent asthma for at least a year,
• received continuous treatment with inhaled steroid and long-acting bronchodilators,
• have had two occasions of worsening asthma requiring steroids in the past year.

You cannot participate in this study if you:

• have cystic fibrosis or any other significant respiratory disorder,
• have smoked more than a pack a day for greater than 10 years,
• have had an asthma attack requiring intubation or cardiac support within 6 months,
• are pregnant or nursing,
• have an uncontrolled disease.

Qualified participants receive:

• Study visits, study medication and related exams are provided at no cost.
• Compensation for time and travel.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.